DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Nakada T, Sugihara K, Jikoh T, Abe Y, Agatsuma T.
The latest research and development into the antibody-drug conjugate, [fam-] trastuzumab deruxtecan (DS-8201a), for HER2 cancer therapy.
Chem Pharm Bull (Tokyo) 2019;
67: 173-85
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.